Mark Dybul
The Honorable Mark Dybul, MD, is the CEO of Enochian BioSciences, Executive Chairperson of Platform Life Sciences and a tenured Professor of Medicine, Georgetown University.
From July 2017 to July 2021 he was the Co-Director of the Center for Global Health Practice and Impact at Georgetown University Medical Center.
Dr. Dybul has worked on HIV and public health for more than 25 years as a clinician, scientist, teacher, and administrator. He served as the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and the US Global Coordinator and Ambassador leading the President’s Emergency Plan for AIDS Relief (PEPFAR) at the level of an Assistant Secretary of State.
After graduating from Georgetown Medical School in Washington D.C., Dr. Dybul joined the National Institute of Allergy and Infectious Diseases, as a research fellow under director Dr. Anthony Fauci, where he conducted basic and clinical studies on HIV virology, immunology and treatment optimization, including the first randomized, controlled trial with combination antiretroviral therapy in Africa.
Mark was one of the founding architects in the formation of PEPFAR. After serving as Chief Medical officer, Assistant, Deputy and Acting Director, he was appointed as its leader in 2006, becoming U.S. Global AIDS Coordinator, with the rank of Ambassador at the level of an Assistant Secretary of State. He served until early 2009.
Mark has written extensively in scientific and policy literature, he is a member of the National Academy of Medicine and has received several Honorary Degrees and awards, including a Doctor of Science, Honoris Causa, from Georgetown University.